
UK researcher: 54,000 women hospitalized in 5 years for abortion pill complications
Carole Novielli
·We are urgently seeking 500 new Life Defenders (monthly supporters) before the end of October to help save babies from abortion 365 days a year. Your first gift as a Life Defender today will be DOUBLED. Click here to make your monthly commitment.
Members of Congress from both parties file dueling briefs in abortion pill case
Hundreds of lawmakers have signed onto amicus briefs designed to sway the Fifth Circuit Court of Appeals in its decision on the Food and Drug Administration’s (FDA) approval of mifepristone, the first drug in the abortion pill regimen.
The dueling briefs come after the Supreme Court sent the case back to the Appeals Court in April. It allowed the pill to remain on the market while the case finished making its way through the court system. The Fifth Circuit is currently reviewing Texas judge Matthew Kacsmaryk’s original decision to upend the FDA’s approval.
Democrats’ brief, filed on May 1, included 203 members of the House and 50 senators. It urged the Fifth Circuit to overturn Kacsmaryk’s decision, arguing that the judge had overstepped his authority by overriding the FDA’s assertion of expertise on the abortion pill’s safety.
“For decades, the federal judiciary has respected Congress’s delegation of the drug approval process to FDA’s scientists and experts,” the lawmakers’ brief read. “While courts have, on occasion, held against FDA on issues related to the market exclusivity that is afforded to a drug sponsor by the statute, it is an extraordinary and unprecedented step for the district court to invalidate on substantive grounds—and over FDA’s objection—a longstanding approval for a drug with a history of safe and effective use. This Court should reverse that aberrant decision and order.”
They added that Kacsmaryk’s decision would hinder abortion access as well as “disrupt industry expectations and could chill pharmaceutical research and development.”
Republicans, meanwhile, filed in support of Kacsmaryk’s decision and criticized the FDA for, among other things, not adequately considering the impacts of the abortion pill on minor patients. It also cited the Comstock Act, which prohibits mailing certain items like abortion pills.
Dear Reader,
Every day in America, more than 2,800 preborn babies lose their lives to abortion.
That number should break our hearts and move us to action.
Ending this tragedy requires daily commitment from people like you who refuse to stay silent.
Millions read Live Action News each month — imagine the impact if each of us took a stand for life 365 days a year.
Right now, we’re urgently seeking 500 new Life Defenders (monthly donors) to join us before the end of October. And thanks to a generous $250,000 matching grant, your first monthly gift will be DOUBLED to help save lives and build a culture that protects the preborn.
Will you become one of the 500 today? Click here now to become a Live Action Life Defender and have your first gift doubled.
Together, we can end abortion and create a future where every child is cherished and every mother is supported.
“By approving and then deregulating chemical abortion drugs, the FDA failed to follow Congress’ statutorily prescribed drug approval process and subverted Congress’ critical public policy interests in upholding patient welfare,” read the brief, which was filed last week.
It continued, “Moreover, the FDA in 2016 eliminated any requirement that adverse non-fatal medical events resulting from chemical abortion be reported to the FDA, then claimed in its 2021 revision that the absence of reported complications demonstrated that chemical abortion was safe. The FDA’s lawless actions have endangered women and girls seeking chemical abortions, and the Court should affirm the District Court’s ruling.”
From the House, 76 members joined the brief. In total, 18 senators signed on with Pro-Life Caucus Chair Cindy Hyde-Smith (R-Miss.) leading the charge. In April, Republicans filed another brief with even fewer members signing.
Republicans’ brief came as the party faced an internal debate over how far they should go in restricting abortion. At least one Republican – Rep. Nancy Mace (R-S.C.) – went so far as to agree with Rep. Alexandria Ocasio-Cortez (D-N.Y.) in calling on the Biden administration to ignore Kacsmaryk’s decision. Others have bristled at federal abortion bans, suggesting the issue should stay in states’ hands.
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Carole Novielli
·Politics
Cassy Cooke
·Guest Column
Right to Life UK
·International
Angeline Tan
·Politics
Bridget Sielicki
·Human Interest
Cassy Cooke
·Human Interest
Sam Dorman
·Activism
Sam Dorman
·Activism
Sam Dorman
·International
Sam Dorman
·Activism
Sam Dorman
·